Rapid Micro Biosystems
Rapid Micro Biosystems announces New Vice President of Operations
LOWELL, Mass., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, a leading provider of automated, non-destructive, rapid microbial detection, is pleased to announce the addition of Mike Noyes as Vice President of Operations. Mike will report directly to the CEO, Robert Spignesi.
Mr. Noyes brings over 25 years of executive Operations experience with leading medical device companies. Most recently, he held the position of Vice President of Operations at Smith Medical, where he successfully developed a new manufacturing footprint and network optimization strategy and managed all North American manufacturing facilities with over 4,000 employees. Previously, Mr. Noyes held multiple Operations positions at Smith Group including VP, Operations North America and Regional Director, Northeast Operations. Mr. Noyes' prior experience includes positions at Medtronic Corporation, Angiolink, Galileo Corporation, Tyco Healthcare, and Cordis.
"I am delighted to have an executive of Mike's caliber and experience to join our executive team," said CEO Robert Spignesi. "His track record of developing operations strategies in addition to optimizing and scaling manufacturing processes across global site networks will be instrumental to our continued growth and success."
"I am excited to join the team at Rapid Micro Biosystems as VP of Operations and take on this assignment as the company develops to become the leader in automated, rapid microbiology detection method," said Mr. Noyes.
Mike holds a M.S. degree in Mechanical Engineering from Columbia University, an MBA from Nova Southeastern University and a B.S. degree in Electrical Engineering from Northeastern University.
About Rapid Micro Biosystems
Rapid Micro Biosystems creates innovative products for fast, accurate, and efficient detection of microbial contamination in the manufacture of pharmaceuticals, biologics, biotechnology products, medical devices, and personal care products. The company's Growth Direct(TM)-the first and only growth-based system to automate compendial testing-detects contamination more quickly, delivering compelling economic benefits to manufacturers while improving their quality control (QC) process.
Rapid Micro Biosystems
Information om Nasdaq OMX
Følg pressemeddelelser fra Nasdaq OMX
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Nasdaq OMX
Abeona Therapeutics Inc20.4.2018 14:16 | pressemeddelelse
Abeona Therapeutics Receives Orphan Drug Designation in the European Union for ABO-202 Gene Therapy Program in Batten Disease
Taconic Biosciences20.4.2018 14:02 | pressemeddelelse
Taconic Biosciences Licenses Easi-CRISPR Technology from the University of Nebraska
Diesel Technology Forum20.4.2018 00:10 | pressemeddelelse
Progress and Potential for Achieving Cleaner Air on a Global Basis
Aryaka19.4.2018 18:56 | pressemeddelelse
SD-WAN for Office 365: Aryaka Helps eLearning company, City & Guilds Group, Improve Office 365 Application Response Time
Taconic Biosciences19.4.2018 14:02 | pressemeddelelse
Taconic Biosciences Launches New Inflammatory Bowel Disease Models
Cisco19.4.2018 14:01 | pressemeddelelse
Cisco ACI Is Data Center Solution of Choice for Service Providers Worldwide
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum